XORTX Therapeutics Inc.
XRTX
$2.33
-$0.1095-4.49%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
11/30/2023
-
The Fly
11/30/2023
-
Globe Newswire
11/29/2023
-
The Fly
11/29/2023
-
Globe Newswire
11/13/2023
-
Seeking Alpha - Healthcare
11/10/2023
-
The Fly
11/10/2023
-
Globe Newswire
11/8/2023
-
Globe Newswire
11/2/2023
-
The Fly
11/2/2023
-
Globe Newswire
10/27/2023
-
Globe Newswire
10/25/2023
-
Globe Newswire
10/25/2023
-
The Fly
10/25/2023
-
Globe Newswire
10/23/2023
-
InvestorPlace
10/20/2023
-
InvestorPlace
10/12/2023
-
Globe Newswire
10/4/2023
-
The Fly
10/4/2023
-
Globe Newswire
9/28/2023
-
The Fly
9/28/2023
-
Globe Newswire
9/7/2023
-
The Fly
9/7/2023
-
Globe Newswire
8/29/2023
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 14, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Week of Mar 25 and 29 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
403 455 7727
Address
3710 – 33rd Street NW
Alberta Beach, AB T2L 2M1
Alberta Beach, AB T2L 2M1
Country
Year Founded
--
Business Description
Sector
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin...
more
